<DOC>
	<DOCNO>NCT02373956</DOCNO>
	<brief_summary>The main objective study document effectiveness honey-based medical device ( Hyalumel ) management pressure ulcer . The effectiveness medical device judge accord evolution surface wind end 12 week treatment .</brief_summary>
	<brief_title>Efficacy Tolerance Honey-impregnated Dressings Local Management Pressure Ulcers</brief_title>
	<detailed_description>The secondary objective study compare follow item two arm study : A . The evolution skin microbiota wound B . The evolution surface depth wound follow-up C. The healing process D. Patient caretaker acceptability</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>Information provide implementation study , objective , constraint patient right The patient , his/her legal guardian , must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient available 12 week followup Presence one pressure ulcer stag 2 , 3 4 accord European Pressure Ulcer Advisory Panel National Pressure Ulcer Advisory Panel ( EPUAPNPUAP ) classification Wound whose surface 1 cm^2 15 cm^2 Wound present 6 week Patient whose wound require modern dress ( say , bandage neither tulle gauze ) without bactericidal agent antibiotics No antibiotic least 7 day prior inclusion ( inclusion , patient treat antibiotic necessary , regardless indication ) Patient participate participate another interventional study previous 3 month currently patient exclusion period determine previous study . Patient judicial protection Failure correctly inform patient his/her legal representative Patient ( his/her legal guardian ) refusal sign consent The patient pregnant , parturient , breastfeed Contraindications ( incompatible combination therapy ) necessary treatment study Patient allergy honey propolis The patient 's general condition suggest study exclusion twelve week followup Antibiotics receive within 7 day prior inclusion Active neoplastic lesion treat radiation chemotherapy Immunosuppressive therapy treatment , judgment investigator , may interfere heal process Surgery plan within twelve week inclusion Stage 1 wound accord EPUAPNPUAP classification Amputation wound Wound relate surgical treatment act revascularization envisage within twelve week inclusion Malignant wound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>